October 24, 2024 – Talk Bio

CDC Recommends Pneumococcal Vaccination for Adults 50 Years and Older

6 months ago talkbio0Tagged Administration of vaccine product containing only Streptococcus pneumoniae antigen (procedure), Adult, Centers for Disease Control and Prevention (U.S.), older, pneumococcal disease prevention, Recommendation, respiratory season

Pneumococcal vaccination, CDC recommendations, adults 50 and older, pneumococcal disease prevention, winter respiratory season.

Roche and Dyno Therapeutics Launch $1B+ Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Neurological Diseases

6 months ago talkbio0Tagged AAVS1 gene, Cloning Vectors, Collaboration, Dyno, gene delivery process, gene therapy, LEAP, Neurological diseases, Roche (company), Technology

Roche, Dyno Therapeutics, AAV gene therapy vectors, Neurological diseases, AI-driven gene delivery, LEAP technology, Gene therapy collaboration

Poseida Therapeutics Advances Non-Viral Gene Editing Therapy for Hereditary Angioedema

6 months ago talkbio0Tagged Angioedemas, Hereditary, Cas-CLOVER, liver-directed gene therapy, non-viral gene, Poseida

Poseida Therapeutics, non-viral gene editing, hereditary angioedema (HAE), P-KLKB1-101, Cas-CLOVER, liver-directed gene therapy

Marinus Pharmaceuticals to Reduce Workforce and Explore Strategic Alternatives Following Disappointing Trial Results

6 months ago talkbio0Tagged Biotech Layoffs, Drug Industry, Marinus Pharmaceuticals, strategic alternatives, Ztalmy trial

Marinus Pharmaceuticals, workforce reduction, strategic alternatives, Ztalmy trial, pharmaceutical industry, biotech layoffs

Thermo Fisher Forecasts Revenue Growth in 2025 Amid Easing Market Challenges

6 months ago talkbio0Tagged 2025, Analytical Instruments, Growth, headwinds, Laboratory Products, pharmaceutical sector, Thermo Fisher Scientific

Thermo Fisher Scientific, revenue forecast, 2025 growth, easing headwinds, biotech funding, pharmaceutical sector, laboratory products, analytical instruments.

Roche CEO Urges Antitrust Regulators to Block Novo Holdings’ Acquisition of Catalent

6 months ago talkbio0Tagged Acquisitions, Catalent, Drug Industry, Holdings, mergers, Regulators (device), Roche (company)

Novo Holdings, Catalent, Roche, Antitrust Regulators, Pharmaceutical Industry, Mergers and Acquisitions

Roche Revisits Dyno for AAV Technology with $50M Upfront Payment

6 months ago talkbio0Tagged AAV, AAVS1 gene, Dyno, gene therapy, Neurological diseases, Roche (company), strategic partnership, Technology

Roche, Dyno Therapeutics, AAV technology, gene therapy, neurological diseases, strategic partnership

Pfizer Announces Additional Layoffs in North Carolina Following DMD Trial Setback

6 months ago talkbio0Tagged cost-cutting measures, gene therapy, Muscular Dystrophy, Duchenne, North Carolina, Pfizer Layoffs, Trial failure

Pfizer layoffs, North Carolina, Duchenne muscular dystrophy (DMD), gene therapy trial failure, cost-cutting measures

Ocuphire Pharma Acquires Opus Genetics, Expanding into Inherited Retinal Disease Gene Therapies

6 months ago talkbio0Tagged Acquisition, Biological Factors, gene therapy, Hereditary, IRDs, Ocuphire Pharma, ophthalmic treatments, Opus, Retinal Diseases, Science of genetics

Ocuphire Pharma, Opus Genetics, gene therapy, inherited retinal diseases (IRDs), merger, acquisition, biopharmaceutical, ophthalmic treatments

Alpha-9 Radios Secures $175M Funding for RLT Portfolio Advancement

6 months ago talkbio0Tagged Alpha-9, Investments, portfolio, Radio communications, Radiopharmaceuticals, RLT

Alpha-9 radios, $175M funding, RLT portfolio, radiopharmaceuticals, biotech investment